Cargando…
Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model
In previous papers, we presented data on studies on the anticancer activity of the vitamin D(3) analogs, named PRI-2191 and PRI-2205, in different cancer models. In this study, we showed the improved antiproliferative activity of a combination of imatinib mesylate (Gleevec, GV) and cytostatic agents...
Autores principales: | Maj, Ewa, Filip-Psurska, Beata, Świtalska, Marta, Kutner, Andrzej, Wietrzyk, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661874/ https://www.ncbi.nlm.nih.gov/pubmed/26580599 http://dx.doi.org/10.3390/ijms161126016 |
Ejemplares similares
-
Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model
por: Maj, Ewa, et al.
Publicado: (2017) -
Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment
por: MILCZAREK, MAGDALENA, et al.
Publicado: (2014) -
Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells
por: Milczarek, Magdalena, et al.
Publicado: (2013) -
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models
por: Filip-Psurska, Beata, et al.
Publicado: (2021) -
Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191
por: Maj, Ewa, et al.
Publicado: (2021)